NCT01670812 2012-08-22Trial of FFP+HDMP+Rituximab for Ultra-high Risk Chronic Lymphocytic LeukemiaThe First Affiliated Hospital with Nanjing Medical UniversityPhase 3 Unknown100 enrolled